Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. - Lust JA; Lacy MQ; Zeldenrust SR; Dispenzieri A; Gertz MA; Witzig TE; Kumar S; Hayman SR; Russell SJ; Buadi FK; Geyer SM; Campbell ME; et al. (Mayo Clinic Proceedings, 2009)